Article

Providing recombinant gonadotropin-based therapies that induce complete oogenesis and…

medRxiv · 2020 · Ramos-Judez, S.; Chauvigne, F.; Gonzalez-Lopez, W. A.; Rosenfeld, H.; Cerda, J.; Gimenez, I.; Duncan, N.

Key facts

Title Providing recombinant gonadotropin-based therapies that induce complete oogenesis and produce viable larvae from an immature teleost, flathead grey mullet (Mugil cephalus)
First author Ramos-Judez, S.; Chauvigne, F.; Gonzalez-Lopez, W. A.; Rosenfeld, H.; Cerda, J.; Gimenez, I.; Duncan, N.
Journal medRxiv
Published Aug 5, 2020
DOI 10.1101/2020.06.04.132175
Devices mentioned BK110039, K103302
Product codes mentioned NDS, PCA, NJT, OOI

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature